Comparing Major and Mild Cognitive Impairment Risks in Older Type-2 Diabetic Patients: a Danish Register-Based Study on Dipeptidyl Peptidase-4 Inhibitors Vs. Glucagon-Like Peptide-1 Analogues
Journal of Neurology（2024）
Abstract
The prevalence of major and mild cognitive impairment (CI) in type-2 diabetes older patients is 15–25
MoreTranslated text
Key words
Glucagon-like peptide-1 analogues,Dipeptidyl peptidase-4 inhibitors,Major cognitive impairment,Mild cognitive impairment,Older individuals,Register-based study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined